https://nl.marketscreener.com/koers/aandeel/ABSCI-CORPORATION-124982799/nieuws/Absci-Corporation-presenteert-preklinische-gegevens-voor-ABS-101-een-potentieel-best-in-class-anti-45691990/?utm_source=telegram&utm_medium=social&utm_campaign=share